Reduced toxicity regimen allogeneic stem cell transplantation. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy30

Stem Cells Hematopoietic Stem Cells Antilymphocyte Serum T-Lymphocytes Embryonic Stem Cells Adult Stem Cells Pluripotent Stem Cells Bone Marrow Cells Bone Marrow Neural Stem Cells Mesenchymal Stromal Cells Cells, Cultured CD8-Positive T-Lymphocytes Induced Pluripotent Stem Cells T-Lymphocytes, Cytotoxic Multipotent Stem Cells Philadelphia Chromosome CD4-Positive T-Lymphocytes Fetal Stem Cells Fetal Blood Killer Cells, Natural Lymphocytes T-Lymphocyte Subsets T-Lymphocytes, Regulatory Allografts Spermatogonia Neoplastic Stem Cells Plant Stems Blood Cells Dendritic Cells

Organisms9

Transplantation Chimera Cytomegalovirus Herpesvirus 6, Human Mice, Inbred C57BL Herpesvirus 4, Human Mice, Inbred BALB C Mice, SCID Radiation Chimera Chimera

Diseases48

Graft vs Host Disease Hematologic Neoplasms Recurrence Leukemia, Myeloid, Acute Multiple Myeloma Leukemia Leukemia, Myelogenous, Chronic, BCR-ABL Positive Cytomegalovirus Infections Myelodysplastic Syndromes Neoplasm, Residual Precursor Cell Lymphoblastic Leukemia-Lymphoma Hepatic Veno-Occlusive Disease Acute Disease Primary Myelofibrosis Anemia, Aplastic Hematologic Diseases Leukemia, Myeloid, Accelerated Phase Roseolovirus Infections Leukemia, Myeloid Lymphoproliferative Disorders Hodgkin Disease Lymphoma, Non-Hodgkin Infection Stomatitis Opportunistic Infections Leukemia, Lymphocytic, Chronic, B-Cell Adenoviridae Infections Lymphoma Mycoses Epstein-Barr Virus Infections Blast Crisis Chronic Disease Lymphoma, Follicular Neoplasms Aspergillosis Philadelphia Chromosome Viremia Neoplasm Recurrence, Local Disease Progression Severe Combined Immunodeficiency Lymphoma, Mantle-Cell Blood Group Incompatibility Disease Models, Animal Iron Overload Postoperative Complications Neutropenia Amyloidosis Precursor B-Cell Lymphoblastic Leukemia-Lymphoma

Chemicals and Drugs52

Myeloablative Agonists Busulfan Vidarabine Immunosuppressive Agents Minor Histocompatibility Antigens Antilymphocyte Serum Melphalan Cyclophosphamide HLA Antigens Antineoplastic Agents Antigens, CD34 Cytarabine Antibodies, Neoplasm Benzamides Fusion Proteins, bcr-abl Receptors, Purinergic P2X5 Pyrimidines Granulocyte Colony-Stimulating Factor Ganciclovir Cyclosporine Piperazines Etoposide Antibodies, Monoclonal Antibodies, Monoclonal, Murine-Derived Vincristine Benzydamine Antiviral Agents Antigens, CD Antibodies, Monoclonal, Humanized Stem Cell Factor Carmustine Antigens, Viral Viral Matrix Proteins Antineoplastic Agents, Alkylating DNA, Viral Thiotepa fms-Like Tyrosine Kinase 3 Thalidomide Cytokines Isoantigens Antigens, Neoplasm Biological Markers Tacrolimus Methotrexate Prednisone HLA-A2 Antigen Doxorubicin Antifungal Agents Interferon-gamma Protein Kinase Inhibitors Recombinant Proteins Dexamethasone

Analytical, Diagnostic and Therapeutic Techniques and Equipment82

Hematopoietic Stem Cell Transplantation Transplantation, Homologous Stem Cell Transplantation Transplantation Conditioning Transplantation, Autologous Peripheral Blood Stem Cell Transplantation Treatment Outcome Bone Marrow Transplantation Remission Induction Histocompatibility Testing Lymphocyte Transfusion Combined Modality Therapy Retrospective Studies Cord Blood Stem Cell Transplantation Salvage Therapy Disease-Free Survival Survival Analysis Whole-Body Irradiation Liver Transplantation Lymphocyte Depletion Survival Rate Antineoplastic Combined Chemotherapy Protocols Mesenchymal Stem Cell Transplantation Hematopoietic Stem Cell Mobilization Follow-Up Studies Cell Transplantation Kidney Transplantation Prognosis Immunosuppression Fatal Outcome Immunotherapy, Adoptive Heart Transplantation Prospective Studies Leukocyte Transfusion Flow Cytometry Transplantation, Isogeneic Lymphocyte Count Immunotherapy Risk Factors Lung Transplantation Actuarial Analysis Polymerase Chain Reaction Clinical Trials as Topic Cytogenetic Analysis Organ Transplantation Immunophenotyping Incidence Islets of Langerhans Transplantation Transplantation Cohort Studies Feasibility Studies Kaplan-Meier Estimate Cell Separation Drug Evaluation Reverse Transcriptase Polymerase Chain Reaction Viral Load Pilot Projects Multivariate Analysis Pancreas Transplantation Leukapheresis Donor Selection Lymphocyte Activation Transplantation, Heterologous Cell Culture Techniques Bone Marrow Purging Drug Administration Schedule Predictive Value of Tests Skin Transplantation Stem Cell Research Life Tables Fetal Tissue Transplantation Toxicity Tests Transplantation, Heterotopic Disease Models, Animal Cell- and Tissue-Based Therapy Blood Component Removal Lymphocyte Culture Test, Mixed Risk Assessment Treatment Failure Case-Control Studies Platelet Transfusion Colony-Forming Units Assay

Psychiatry and Psychology2

Siblings Nuclear Family

Phenomena and Processes29

Graft vs Leukemia Effect Graft vs Tumor Effect Graft Survival Virus Activation Histocompatibility Chimerism Time Factors Transplantation Immunology Immunocompromised Host Graft Rejection Cell Differentiation Lymphocyte Count Stem Cell Niche T-Cell Antigen Receptor Specificity Cell Proliferation Philadelphia Chromosome Hematopoiesis Cell Lineage Transplantation Tolerance Viral Load Cytotoxicity, Immunologic Lymphocyte Activation Regeneration Drug Resistance, Neoplasm Cell Survival Dose-Response Relationship, Drug Karyotype Radiation Chimera Graft vs Host Reaction

Disciplines and Occupations2

Hematology Stem Cell Research

Anthropology, Education, Sociology and Social Phenomena2

Siblings Nuclear Family

Information Science4

Survival Rate Fatal Outcome Incidence Life Tables

Named Groups5

Tissue Donors Siblings Living Donors Blood Donors Unrelated Donors

Health Care24

Treatment Outcome Retrospective Studies Disease-Free Survival Survival Analysis Survival Rate Follow-Up Studies Fatal Outcome Prospective Studies Risk Factors Actuarial Analysis Clinical Trials as Topic Incidence Cohort Studies Feasibility Studies Kaplan-Meier Estimate Pilot Projects Multivariate Analysis Donor Selection Predictive Value of Tests Life Tables Risk Assessment Treatment Failure Case-Control Studies Age Factors

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Information Science Named Groups Health Care Geographicals

Hematopoietic Stem Cell Transplantation Transplantation, Homologous Stem Cell Transplantation Graft vs Host Disease Transplantation Conditioning Transplantation, Autologous Peripheral Blood Stem Cell Transplantation Hematologic Neoplasms Transplantation Chimera Stem Cells Treatment Outcome Graft vs Leukemia Effect Bone Marrow Transplantation Myeloablative Agonists Busulfan Tissue Donors Remission Induction Vidarabine Recurrence Graft vs Tumor Effect Graft Survival Histocompatibility Testing Lymphocyte Transfusion Immunosuppressive Agents Leukemia, Myeloid, Acute Multiple Myeloma Leukemia Combined Modality Therapy Retrospective Studies Siblings Cord Blood Stem Cell Transplantation Leukemia, Myelogenous, Chronic, BCR-ABL Positive Salvage Therapy Cytomegalovirus Infections Disease-Free Survival Hematopoietic Stem Cells Minor Histocompatibility Antigens Survival Analysis Whole-Body Irradiation Liver Transplantation Lymphocyte Depletion Survival Rate Antilymphocyte Serum Myelodysplastic Syndromes Virus Activation Neoplasm, Residual Precursor Cell Lymphoblastic Leukemia-Lymphoma Histocompatibility Antineoplastic Combined Chemotherapy Protocols Melphalan Chimerism Cyclophosphamide Time Factors Hepatic Veno-Occlusive Disease Mesenchymal Stem Cell Transplantation Hematopoietic Stem Cell Mobilization Cytomegalovirus T-Lymphocytes Acute Disease Primary Myelofibrosis Follow-Up Studies Anemia, Aplastic Cell Transplantation Kidney Transplantation Hematologic Diseases HLA Antigens Prognosis Embryonic Stem Cells Leukemia, Myeloid, Accelerated Phase Antineoplastic Agents Antigens, CD34 Cytarabine Antibodies, Neoplasm Transplantation Immunology Immunosuppression Roseolovirus Infections Benzamides Adult Stem Cells Leukemia, Myeloid Immunocompromised Host Lymphoproliferative Disorders Fusion Proteins, bcr-abl Hodgkin Disease Receptors, Purinergic P2X5 Pyrimidines Lymphoma, Non-Hodgkin Graft Rejection Nuclear Family Granulocyte Colony-Stimulating Factor Ganciclovir Cyclosporine Infection Piperazines Fatal Outcome Immunotherapy, Adoptive Stomatitis Heart Transplantation Opportunistic Infections Cell Differentiation Etoposide

No FAQ available that match "reduced toxicity regimen allogeneic stem cell transplantation"